Studying the frequency of patients with myocarditis and Kawasaki disease and related demographic and laboratory findings during the years 1396 to 1401 in Amirulmomenin educational and therapeutic hospital in Semnan city.

Document Type : Original Article

Authors

1 Assistant Professor of Cardiology Department of Pediatrics, School of Medicine Semnan University of Medical Sciences

2 Assistant Professor of Pediatric Endocrinology & Metabolism Department of Pediatrics, School of Medicine Semnan University of Medical Sciences. Department of Pediatrics, School of Medicine Semnan University of Medical Sciences

3 Assistant Professor of Neonatal-Perinatal Medicine Department of Pediatrics, School of Medicine Semnan University of Medical Sciences. Department of Pediatrics, School of Medicine Semnan University of Medical Sciences

4 Semnan University of Medical Sciences

5 Assistant Professor of EpidemiologyDepartment of Community Medicine, School of MedicineSocial Determinants of Health Research Center.Semnan University of Medical Sciences

10.22118/jsmj.2024.418812.3255

Abstract

Introduction: Considering the spread of Covid-19, it is important to know its complications. In the present study, we examined the frequency of patients with myocarditis and Kawasaki disease and related demographic and laboratory findings in children before and during covid-19.
Materials and methods: The present study was carried out in a descriptive-analytical manner on patients with myocarditis or Kawasaki disease during the years 2016 to 2016. During this study, demographic information, laboratory variables of the child were collected from the patients' files and statistically analyzed using SPSS version 24 software.
Findings: In this study, 65 patients (31 girls and 34 boys) with an average age of 41.28 ± 3.9 months were examined. Of these, 46 people (69.7%) had Kawasaki disease and 19 (28.8%) had myocarditis. The condition of being infected with Covid-19 was also observed in 22 of the patients (33.3%). The rate of hospitalization with the diagnosis of Kawasaki disease after Covid-19 was significantly higher than before [27 cases (58.7%) against 19 cases ( 41.3%)], while the hospitalization rate with the diagnosis of myocarditis decreased significantly after the onset of corona [1 case (5.3%) vs. 1 case (5.3%), (P<0.001)].
Conclusion: According to the results, the hospitalization rate with the diagnosis of Kawasaki disease after the occurrence of covid-19 was significantly higher than before, and the frequency of patients with Kawasaki disease with and without covid-19 was not significantly different.

Keywords

Main Subjects

References

[1] Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of infection and public health. 2020 Dec 1;13(12):1791-6. [10.1016/j.jiph.2020.10.008 ] [PMID]
[2] Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. Journal of infection and public health. 2020 Dec 1;13(12):1791-6. [10.1016/j.jiph.2020.10.008 ] [PMID]
[3] Laukka D, Parkkola R, Hirvonen J, Ylikotila P, Vahlberg T, Salo E, Kivelev J, Rinne J, Rahi M. Brain white matter hyperintensities in Kawasaki disease: A case–control study. Frontiers in Neuroscience. 2022 Oct 18;16:995480. [10.3389/fnins.2022. 995480 ] [PMID]
[4] Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nature Reviews Rheumatology. 2020 Jul;16(7):391-405. [10.1038/s41584-020-0426-0 ] [PMID]
[5] Soni PR, Noval Rivas M, Arditi M. A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Current Rheumatology Reports. 2020;22(2):6. [10.1007/s11926-020-0882-1 ] [PMID]
[6] Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Archives of pediatrics & adolescent medicine. 2006 Jul 1;160(7):686-90. [10.1001/archpedi.160.7.686 ] [PMID]
[7] Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Archives of pediatrics & adolescent medicine. 2006 Jul 1;160(7):686-90. [10.1001/archpedi.160.7.686 ] [PMID]
[8] Eun LY, Kim JH, Jung JW, Choi JY. Myocardial layers specific strain analysis for the acute phase of infant Kawasaki disease. Pediatric cardiology. 2016 Dec;37:1404-8. [10.1007/s00246-016-1448-x ] [PMID]
[9] Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem inflammatory syndrome in children (MIS-C) with COVID-19: insights from simultaneous familial Kawasaki disease cases. International Journal of Infectious Diseases. 2020 Aug 1;97:371-3. [10.1016/j.ijid.2020.06.014 ] [PMID]
[10] Iio K, Matsubara K, Miyakoshi C, Ota K, Yamaoka R, Eguchi J, Matsumura O, Okutani T, Ueda I, Nishiyama M. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ paediatrics open. 2021;5(1). [10.1136/bmjpo-2021-001034 ] [PMID]
[11] Alizargar J. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. Journal of the Formosan Medical Association. 2020 Nov;119(11):1713. [10.1016/j.jfma.2020.05. 030] [PMID]
[12] Rathore SS, Rojas GA, Sondhi M, Pothuru S, Pydi R, Kancherla N, Singh R, Ahmed NK, Shah J, Tousif S, Baloch UT. Myocarditis associated with Covid‐19 disease: a systematic review of published case reports and case series. International journal of clinical practice. 2021 Nov;75(11):e14470. [10.1111/ijcp.14470] [PMID]
[13] Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M,
Salerno C, Hernandez-Montfort J, Islam AM. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovascular Revascularization Medicine. 2021 Feb 1;23:107-13. [10.1016/j.carrev.2020.08.028 ] [PMID]
[14] Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, Hernandez-Montfort J, Islam AM. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovascular Revascularization Medicine. 2021 Feb 1;23:107-13. [10.1016/j.carrev.2020.08.028 ] [PMID]
[15] Beşler MS, Arslan H. Acute myocarditis associated with COVID-19 infection. The American journal of emergency medicine. 2020;38(11):2489.e1-.e2. [10.1016/j.carrev.2020.08.028] [PMID]
[16] Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet (London, England). 2020;395(10239):1771-8. [10.1016/S0140-6736(20)31103-X] [PMID]
[17] Esmaeilzadeh H, Mortazavi N, Salehi A, Fatemian H, Dehghani SM, Vali M, Vardanjani HM. Effect of COVID-19 on Kawasaki disease: decrease age of onset and increase skin manifestation. BMC pediatrics. 2021 Dec;21:1-6. [10.1186/s12887-021-03060-w] [PMID]
[18] Shahbaznejad L, Navaeifar MR, Abbaskhanian A, Hosseinzadeh F, Rahimzadeh G, Rezai MS. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran. BMC pediatrics. 2020 Dec;20:1-2. [10.1186/s12887-020-02415-z ] [PMID]
[19] Nihal NG, Challuri P, Reddy MPK, Babu RS. Stress and anxiety among medical interns and doctors deputed in COVID duties: A cross-sectional study. Telangana Journal of Psychiatry. 2021;7(2):122. [Link]
[20] Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M, Léger PL, Galeotti C, Claude C, Wiedemann A, Lachaume N. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. Jama. 2021 Mar 2;325(9):855-64. [10.1001/jama.2021.0694 ] [PMID]
[21] Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Jama. 2020 Jul 21;324(3):259-69. [10.1001/jama.2020. 10369] [PMID]
[22] Ziaee V, Assari R, Mamishi S, Zeinaloo A, Mohammadpour M, Malekzadeh I, COVID MC. An algorithmic approach to multisystem inflammatory syndrome in children with COVID-19: tehran children’s medical center protocol. Iranian Journal of Pediatrics. 2020 Oct 31;30(5). [Link]
[23] Beşler MS, Arslan H. Acute myocarditis associated with COVID-19 infection. The American Journal of Emergency Medicine. 2020;38(11):2489.e1-.e2. [10.1016/j.carrev.2020.08.028] [PMID]
[24] Kariyanna PT, Sutarjono B, Grewal E, Singh KP, Aurora L, Smith L, Chandrakumar HP, Jayarangaiah A, Goldman SA, Salifu MO, McFarlane IM. A systematic review of COVID-19 and myocarditis. American journal of medical case reports. 2020;8(9):299. [Link]
[25] Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY,
Jundishapur
Scientific Medical Journal
January & February 2024. Vol 22. No 6
Tajdini P, et al. Frequency of Myocarditis and Kawasaki Disease. JSMJ. 2024; 22(6):757-767
767
Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26;110(17):2747-71 [10.1161/01.CIR.0000145143.19711.78 ] [PMID]
[26] Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology?. International journal of infectious diseases. 2005 Jul 1;9(4):185-94. [PMID]
[27] Mardi P, Esmaeili M, Iravani P, Abdar ME, Pourrostami K, Qorbani M. Characteristics of children with Kawasaki disease-like signs in COVID-19 pandemic: a systematic review. Frontiers in pediatrics. 2021 Mar 18;9:625377.. [10.3389/fped.2021.625377 ] [PMID]
Jundishapur Scientific Medical Journal
Volume 22, Issue 6 - Serial Number 147
January and February 2023
Pages 757-767

Files

History

  • Receive Date: 01 October 2023
  • Revise Date: 29 January 2024
  • Accept Date: 03 February 2024

Share

How to cite

Statistics